Sofosbuvir/Velpatasvir · more major-labeled pairs than Dabigatran

SPL labels Sofosbuvir/Velpatasvir + Dabigatran as minor; Sofosbuvir/Velpatasvir 20 / Dabigatran 12 in that band.

Mechanism on file: This combination can raise the amount of dabigatran in your blood.

FDA SPL severity: Minor

Sofosbuvir/Velpatasvir

Full Sofosbuvir/Velpatasvir label record

NS5B/NS5A Inhibitor (HCV)

Dabigatran

Full Dabigatran label record

Direct Thrombin Inhibitor

Sofosbuvir/Velpatasvir + Dabigatran · SPL mechanism field

This combination can raise the amount of dabigatran in your blood.

Minor band excerpt · Sofosbuvir/Velpatasvir with Dabigatran

Anticoagulants: dabigatran etexilate ↑ dabigatran Clinical monitoring of dabigatran is recommended when coadministered with VOSEVI. Refer to dabigatran etexilate prescribing information for dose modification recommendations in the setting of moderate renal impairment.

Sofosbuvir/Velpatasvir · 3 major-labeled pairs (vs Dabigatran's 0)

View all Sofosbuvir/Velpatasvir interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.